Q1 2025 Tenet Healthcare Corp Earnings Call Transcript
Key Points
- Tenet Healthcare Corp (THC) reported first-quarter 2025 net operating revenues of $5.2 billion and consolidated adjusted EBITDA of $1.163 billion, representing a 14% growth over 2024.
- The adjusted EBITDA margin improved by 320 basis points to 22.3% in the first quarter of 2025, indicating strong growth and operating discipline.
- USPI's adjusted EBITDA grew 16% over the previous year, with same-facility revenues increasing by 6.8%, driven by a 12% growth in total joint replacements.
- The Hospital Segment's adjusted EBITDA grew 12% to $707 million, with same-store hospital admissions up 4.4% and revenue per adjusted admission up 2.8%.
- THC has significantly deleveraged its balance sheet, achieving a net debt to EBITDA minus NCI ratio of 3:1, providing financial flexibility for capital deployment and shareholder value creation.
- Despite strong first-quarter performance, THC is not updating its full-year 2025 guidance, citing the early stage of the year and potential uncertainties.
- The company faces ongoing healthcare policy uncertainty, which could impact future operations and financial performance.
- There is a noted decrease in case volumes by 2.1% at USPI, reflecting a shift towards higher acuity services, which may impact overall volume growth.
- THC's reliance on Medicaid supplemental revenues, with $35 million of net revenues from Tennessee programs not yet fully approved, poses a risk to future revenue streams.
- The company acknowledges potential challenges in maintaining labor performance improvements, particularly in managing contract labor and retaining staff.
Good morning, and welcome to Tenet Healthcare's first-quarter 2025 earnings conference call. (Operator Instructions)
I'll now turn the call over to your host, Mr. Will McDowell, Vice President of Investor Relations. Mr. McDowell, you may begin.
Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We're pleased to have you join us for a discussion of Tenet's first-quarter 2025 results as well as a discussion of our financial outlook.
Tenet senior management participating in today's call will be Dr. Saumya Sutaria, Chairman and Chief Executive Officer; and Sun Park, Executive Vice President and Chief Financial Officer.
Our webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

